 | ||||||
| Ebola | ||||||
| NEWS | ||||||
| Will GEOVAX LABS INC (OTCMKTS:GOVX) Run Out of Steam Soon? Short Interest Is Down It is developing various vaccines that are in human clinical trials, and preclinical research and development phases, including vaccines against human immunodeficiency virus ; Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines ...
| ||||||
| Novavax Inc (NASDAQ:NVAX) Shorts Rose By 10.12% ... years of age in Phase I development stage.Last it reported negative earnings. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates.
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar